(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 4.95% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Bausch & Lomb's revenue in 2025 is $4,976,000,000.On average, 17 Wall Street analysts forecast BLCO's revenue for 2025 to be $1,834,703,081,120, with the lowest BLCO revenue forecast at $1,754,656,189,936, and the highest BLCO revenue forecast at $1,897,040,483,104. On average, 17 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,941,314,206,104, with the lowest BLCO revenue forecast at $1,847,808,103,128, and the highest BLCO revenue forecast at $2,036,237,068,216.
In 2027, BLCO is forecast to generate $2,035,174,498,864 in revenue, with the lowest revenue forecast at $1,919,708,629,280 and the highest revenue forecast at $2,130,097,360,976.